The worldwide war on baby girls
By The Economist,
The Economist
| 03. 04. 2010
Xinran Xue, a Chinese writer, describes visiting a peasant family in the Yimeng area of Shandong province. The wife was giving birth. "We had scarcely sat down in the kitchen", she writes, "when we heard a moan of pain from the bedroom next door…The cries from the inner room grew louder-and abruptly stopped. There was a low sob, and then a man's gruff voice said accusingly: 'Useless thing!'
"Suddenly, I thought I heard a slight movement in the slops pail behind me," Miss Xinran remembers. "To my absolute horror, I saw a tiny foot poking out of the pail. The midwife must have dropped that tiny baby alive into the slops pail! I nearly threw myself at it, but the two policemen [who had accompanied me] held my shoulders in a firm grip. 'Don't move, you can't save it, it's too late.'
"'But that's...murder...and you're the police!' The little foot was still now. The policemen held on to me for a few more minutes. 'Doing a baby girl is not a big thing around here,' [an] older woman said comfortingly...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...